BIOFORCE NANOSCIENCES HOLDINGS, INC.
Income Statement
| Line Item | Aug 2024 | Jun 2024 | May 2024 | Apr 2024 | Mar 2024 | Dec 2023 | Oct 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | — | $8.7K | — | — | $25.1K | — | — | $7.9K |
| Operating Income | — | $-114.4K | — | — | — | — | — | — |
| Operating Margin | — | — | — | — | — | — | — | — |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | — | — | — | — |
| Net Income | — | $-114.4K | — | — | $-130.8K | — | — | $-113.6K |
| Net Margin | — | — | — | — | — | — | — | — |
| EPS (Basic) | — | $0.00 | — | — | $0.00 | — | — | $0.00 |
| EPS (Diluted) | — | $0.00 | — | — | $0.00 | — | — | $0.00 |
| Shares Outstanding (Basic) | 29.3M | 29.3M | 29.3M | 29.3M | 29.3M | 29.3M | 29.3M | 29.3M |
| Shares Outstanding (Diluted) | 29.3M | 29.3M | 29.3M | 29.3M | 29.3M | 29.3M | 29.3M | 29.3M |
| Dividends Per Share | — | — | — | — | — | — | — | — |
Find something you enjoy doing and give it everything you've got, and the money will take care of itself.